How Lululemon’s founder is looking to restore investors’ faith as a new CEO is picked
Lululemon founder and large shareholder Chip Wilson is looking to restore investor faith in the yoga-gear maker by changing the makeup of the board of…
Tag: News Feed
Strategy’s stock falls to fresh lows after using more share sales to buy bitcoin
The company’s shares fell to a 15-month low amid a decline in bitcoin prices and another dilutive share sale. View Source Tomi Kilgore MarketWatch.com –…
Beyoncé just became a billionaire. Here’s how she did it.
Beyoncé is just the fifth musical artist to achieve billionaire status. View Source Weston Blasi MarketWatch.com – Top Stories December 29, 2025 3:00 pm
Trump eyes January for announcement of Powell replacement as he renews attacks on Fed chief
President Donald Trump on Monday revived his threat to sue over Federal Reserve building renovations. View Source Robert Schroeder MarketWatch.com – Top Stories December 29,…
This winning fund manager spills 4 secrets about smart ways to buy non-U.S. stocks
David Herro is an experienced guide to the global market. View Source Michael Brush MarketWatch.com – Top Stories December 29, 2025 1:30 pm
Why your kitchen cabinets and furniture could get more expensive next year
Prices for some everyday home items may be about to get more expensive, as U.S. tariff rates on imports of certain furniture and kitchen cabinets…
‘The bulls are definitely spooked’: Has silver’s stunning rise this year run out of steam?
Thin holiday trading, higher margin costs and other factors are taking some of the luster off silver’s mega-rally in 2025. View Source Joy Wiltermuth MarketWatch.com…
The miracle of curing Alzheimer’s? No longer an impossibility.
More research shows the disease may one day be reversible. View Source Brett Arends MarketWatch.com – Top Stories December 29, 2025 11:21 am
If I Could Retire With Only 3 Dividend Growth Investments
View Source Most popular articles December 29, 2025 11:05 am
These biotech stocks are getting hammered by shocking brittle-bone treatment study results
Shares of both Ultragenyx and Mereo BioPharma were seeing record selloffs after disappointing trial results for setrusumab. View Source Tomi Kilgore MarketWatch.com – Top Stories…